Page
%P
-
Chapter and Conference Paper
High-dose chemotherapy with hematologic rescue for high-risk non-seminomatous germ cell tumors
Despite progress in the treatment of disseminated non-seminomatous germ cell tumors (NSGCT), 20–30%of patients do not achieve CR or relapse [1]. We evaluated high-dose chemotherapy (HDC) followed by autologous...